Lista de obras - Soheil Tavakolpour - Dominio Público Uruguay

"Change over time in the treatment of pemphigus vulgaris between 2004 and 2016 in Iran": A multiple cross-sectional study

artículo científico publicado en 2019

Anti-desmoglein-1 levels as predictor of prednisolone tapering in pemphigus vulgaris patients treated with rituximab

artículo científico publicado en 2018

Association of Plasma Levels of Vitamin D With Chronic Hepatitis B Infection

artículo científico publicado en 2016

Blockage of T Cell Activation via Anti-CD40 and Anti-CD154 Monoclonal Antibodies can Possibility Treat Alopecia Areata

Changes in induced regulatory T cells by interleukin 35 during atopic dermatitis

artículo científico publicado en 2016

Comparing early and late treatments with rituximab in pemphigus vulgaris: which one is better?

scientific article published on 01 December 2018

Comparing efficacy and safety of potassium hydroxide 5% solution with 5-fluorouracil cream in patients with actinic keratoses: a randomized controlled trial

scientific article published on 02 September 2020

Comparing the short-term therapeutic effects and safety profiles of rituximab therapy in pemphigus vulgaris patients either early treated or later than six months

scientific article published on 12 September 2018

Complex Interaction Between Diphenylcyclopropenone and Immune Responses in Alopecia Areata

artículo científico publicado en 2016

Concomitant bullous pemphigoid and palmoplantar keratoderma: A report of three cases and review of literature

artículo científico publicado en 2020

Corrigendum to "The possible role of interleukin-35 and its therapeutic potential in pemphigus" [Int. Immunol. 42 (2017) 11-17].

artículo científico publicado en 2017

Cryotherapy plus oral zinc sulfate versus cryotherapy plus placebo to treat common warts: A double blind, randomized, placebo-controlled trial.

artículo científico publicado en 2017

Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?

artículo científico publicado en 2017

Decreased serum levels of interleukin-17, interleukin-23, TGF-β in pemphigus vulgaris patients and their association with disease phase

artículo científico publicado en 2020

Desquamative gingivitis in a pemphigus vulgaris patient resistant to rituximab

scientific article published on 17 January 2020

Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus

artículo científico publicado en 2016

Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-Screened

artículo científico publicado en 2016

Inhibition of regulatory cells as a possible cure of chronically hepatitis B virus infected patients

artículo científico publicado en 2015

Interleukin 21 as a new possible player in pemphigus: Is it a suitable target?

artículo científico publicado en 2016

Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.

artículo científico publicado en 2016

Iranian guideline for rituximab therapy in pemphigus patients

artículo científico publicado en 2019

Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata.

artículo científico publicado en 2016

Lichen planopilaris: Retrospective study on the characteristics and treatment of 291 patients

artículo científico publicado en 2019

Management of pemphigus disease in pregnancy

artículo científico publicado en 2016

Manipulation of Regulatory Cells' Responses to Treatments for Chronic Hepatitis B Virus Infection

artículo científico publicado en 2016

New Insights into the Management of Patients with Autoimmune Diseases or Inflammatory Disorders During Pregnancy

artículo científico publicado en 2016

Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review

artículo científico publicado en 2017

Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: A randomized controlled trial

artículo científico publicado en 2020

Paradoxical reaction to rituximab in patients with pemphigus: a report of 10 cases

scientific article published on 27 January 2020

Pathogenic and protective roles of cytokines in pemphigus: A systematic review

artículo científico publicado en 2020

Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus

artículo científico publicado en 2017

Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases

artículo científico publicado en 2017

Regulatory Responses during Chronic Hepatitis B Virus Infection

artículo científico publicado en 2017

Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients

artículo científico publicado en 2020

Rituximab monotherapy in mild pemphigus

artículo científico publicado en 2020

Single-nucleotide polymorphisms associated with pemphigus vulgaris: Potent markers for better treatment and personalized medicine

scientific article published on 24 July 2019

Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review

artículo científico publicado en 2017

The dual nature of retinoic acid in pemphigus and its therapeutic potential: Special focus on all-trans Retinoic Acid

artículo científico publicado en 2016

The elevated level of osteopontin in patients with pemphigus vulgaris: A cytokine-like protein with a therapeutic potential

scientific article published on 07 June 2019

The ignored roles of microRNAs in alopecia areata.

artículo científico publicado en 2017

The new insight into management of hepatitis B virus patients with flare.

artículo científico publicado en 2016

The possible role of interleukin-35 and its therapeutic potential in pemphigus

artículo científico publicado en 2016

The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature

artículo científico publicado en 2016

Tofacitinib as the potent treatment for refractory pemphigus: A possible alternative treatment for pemphigus

scientific article published on 11 September 2018

Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy.

artículo científico publicado en 2017

Towards personalized medicine for patients with autoimmune diseases: Opportunities and challenges

artículo científico publicado en 2017

Treatment of pemphigus patients in the COVID-19 era: a specific focus on rituximab

artículo científico publicado en 2020

Treatment of port wine stains with 595-nm pulsed dye laser in 27 pediatric patients: A prospective study in the Iranian population

scientific article published on 15 September 2019

Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis

artículo científico publicado en 2016

Lista de obras de Soheil Tavakolpour

"Change over time in the treatment of pemphigus vulgaris between 2004 and 2016 in Iran": A multiple cross-sectional study

Anti-desmoglein-1 levels as predictor of prednisolone tapering in pemphigus vulgaris patients treated with rituximab

Association of Plasma Levels of Vitamin D With Chronic Hepatitis B Infection

Blockage of T Cell Activation via Anti-CD40 and Anti-CD154 Monoclonal Antibodies can Possibility Treat Alopecia Areata

Changes in induced regulatory T cells by interleukin 35 during atopic dermatitis

Comparing early and late treatments with rituximab in pemphigus vulgaris: which one is better?

Comparing efficacy and safety of potassium hydroxide 5% solution with 5-fluorouracil cream in patients with actinic keratoses: a randomized controlled trial

Comparing the short-term therapeutic effects and safety profiles of rituximab therapy in pemphigus vulgaris patients either early treated or later than six months

Complex Interaction Between Diphenylcyclopropenone and Immune Responses in Alopecia Areata

Concomitant bullous pemphigoid and palmoplantar keratoderma: A report of three cases and review of literature

Corrigendum to "The possible role of interleukin-35 and its therapeutic potential in pemphigus" [Int. Immunol. 42 (2017) 11-17].

Cryotherapy plus oral zinc sulfate versus cryotherapy plus placebo to treat common warts: A double blind, randomized, placebo-controlled trial.

Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?

Decreased serum levels of interleukin-17, interleukin-23, TGF-β in pemphigus vulgaris patients and their association with disease phase

Desquamative gingivitis in a pemphigus vulgaris patient resistant to rituximab

Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus

Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-Screened

Inhibition of regulatory cells as a possible cure of chronically hepatitis B virus infected patients

Interleukin 21 as a new possible player in pemphigus: Is it a suitable target?

Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.

Iranian guideline for rituximab therapy in pemphigus patients

Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata.

Lichen planopilaris: Retrospective study on the characteristics and treatment of 291 patients

Management of pemphigus disease in pregnancy

Manipulation of Regulatory Cells' Responses to Treatments for Chronic Hepatitis B Virus Infection

New Insights into the Management of Patients with Autoimmune Diseases or Inflammatory Disorders During Pregnancy

Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review

Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: A randomized controlled trial

Paradoxical reaction to rituximab in patients with pemphigus: a report of 10 cases

Pathogenic and protective roles of cytokines in pemphigus: A systematic review

Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus

Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases

Regulatory Responses during Chronic Hepatitis B Virus Infection

Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients

Rituximab monotherapy in mild pemphigus

Single-nucleotide polymorphisms associated with pemphigus vulgaris: Potent markers for better treatment and personalized medicine

Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review

The dual nature of retinoic acid in pemphigus and its therapeutic potential: Special focus on all-trans Retinoic Acid

The elevated level of osteopontin in patients with pemphigus vulgaris: A cytokine-like protein with a therapeutic potential

The ignored roles of microRNAs in alopecia areata.

The new insight into management of hepatitis B virus patients with flare.

The possible role of interleukin-35 and its therapeutic potential in pemphigus

The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature

Tofacitinib as the potent treatment for refractory pemphigus: A possible alternative treatment for pemphigus

Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy.

Towards personalized medicine for patients with autoimmune diseases: Opportunities and challenges

Treatment of pemphigus patients in the COVID-19 era: a specific focus on rituximab

Treatment of port wine stains with 595-nm pulsed dye laser in 27 pediatric patients: A prospective study in the Iranian population

Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis